# Advisor Review - Advisor 2/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-28T19:16:56.065558
**Response ID:** resp_06807e3e2ea3545d00697a5134a8b88194accb747501e045ed
**Tokens:** 20637 in / 5368 out
**Response SHA256:** eee3157e170baeb2

---

## 1) DATA–DESIGN ALIGNMENT (CRITICAL)

### a) Treatment timing vs. data coverage
- Data window is **1999–2017**.
- Maximum “first full treatment year” used in main analysis is **2017 (Washington)**.
- This satisfies **max(treatment year) ≤ max(data year)**. No misalignment found.

### b) Post-treatment observations exist for treated cohorts
- Main spec (excluding CT) uses **Indiana (2006), California (2016), Washington (2017)**.
- Post-treatment years within the data:
  - Indiana: **2006–2017 (12 years)**
  - California: **2016–2017 (2 years)**
  - Washington: **2017 (1 year)**
- So each treated cohort has at least one post-treatment observation. No fatal error.

### c) Treatment definition consistency across tables/text
- Treatment is consistently defined as **first full calendar year in force**; “transition years” are coded pre-treatment.
- Table 1 timing matches the regression cohort coding described (CT 2000, IN 2006, CA 2016, WA 2017).
- Observation counts check out:
  - Full panel: **51×19 = 969** (reported)
  - Excluding CT: **50×19 = 950** (reported)
  - Excluding CT & WA: **49×19 = 931** (reported)
- No internal treatment-timing inconsistency found.

## 2) REGRESSION SANITY (CRITICAL)

Checked Table 3 and Table 4 for impossible/implausible outputs:
- No **NA/NaN/Inf**, no negative SEs.
- Coefficients are in plausible ranges for “suicides per 100,000” and for log outcomes.
- SEs are not explosively large relative to coefficients (e.g., Table 3 C-S: 0.53 with SE 0.19; TWFE: −0.43 with SE 0.65).
- No R² issues are shown (and none reported incorrectly).
No fatal regression-output problems found.

## 3) COMPLETENESS (CRITICAL)

- Regression tables report **effect estimates + SEs + sample sizes (N/observations) + units/years/cohorts** (Table 3, Table 4).
- Robustness checks referenced in the text are actually reported (Table 4).
- Figures referenced (Figures 1–4) appear present in the draft materials provided.
- No placeholders (“TBD”, “TODO”, “XXX”) detected.
No fatal completeness problems found.

## 4) INTERNAL CONSISTENCY (CRITICAL)

- Numbers cited in the abstract match Table 3 (ATT **0.53**, SE **0.19**; TWFE **−0.43**, SE **0.65**).
- Sample definitions match across text and tables (e.g., exclusion of CT yields **950** observations).
- Timing statements are consistent (WA effective Dec 2016 but first full-year treatment coded as 2017).
No fatal internal inconsistencies found.

ADVISOR VERDICT: PASS